Any pause in taking the osteoporosis drug risedronate (Actonel) should last no longer than 2 years rather than the 2 to 3 years currently recommended for bisphosphonates, new research suggests.
In a cohort...
A cellular protein whose normal function appears to suppress bone formation may be a potential new target for treating osteoporosis, suggests a collaborative study led by Weill Cornell Medicine and NewYork-Presbyterian...
Five years of treatment with bisphosphonates after chemotherapy for high-risk early breast cancer is too much, say researchers reporting new results from a phase 3 trial with almost 3000 women.
Current...
Osteoporosis is a condition that does not exhibit symptoms until there is a bone fracture, so a large percentage of patients remain unaware of their condition. When people are unaware their bones have...
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia.
HYSONE
contains the active ingredient hydrocortisone
CONSUMER MEDICINE INFORMATION
What is in this...
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia.
EVIFYNE® V11219
Raloxifene hydrochloride
Consumer Medicine Information
What is in this leaflet
This...
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia.
MADOPAR 190718
(levodopa and benserazide)
Consumer Medicine Information
What is in this leaflet
This...
A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients.
The work is supported by the National Institutes of Health...
A new study reveals that many older men who experience a fracture are still underdiagnosed with and undertreated for osteoporosis. Details of the study was presented at ACR Convergence, the American College...
The osteoporosis wonder drug that helps rebuild crumbling bones and could save 500,000 people a year a visit to the fracture clinic
More than three million Britons suffer from the brittle bone disease...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
